IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding IDEAYA Biosciences, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 91 | 110 | +19 |
| Shares | 32.9M | 34.7M | +1.86M (+5.7%) |
| Value | $837.9M | $820.7M | −$17.2M (−2.1%) |
New holders (27)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (8)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Massachusetts Financial Services Co | 90,199 | $2.30M |
| Bank of Montreal | 56,310 | $1.42M |
| Renaissance Technologies LLC | 29,600 | $755.0K |
| Susquehanna Fundamental Investments, LLC | 14,016 | $357.0K |
| O'Shaughnessy Asset Management, LLC | 2,196 | $56.0K |
| Penserra Capital Management LLC | 880 | $22.0K |
| Group One Trading, L.P. | 518 | $13.0K |
| Harbour Investments, Inc. | 8 | $0 |